Patterns of serotonergic antidepressant usage in prodromal Huntington disease

详细信息    查看全文

• 作者：Kelly C. Rowe^a ; ^b ; Jane S. Paulsen^a ; ^b ; ^c ; ^d ; ^{jane-paulsen@uiowa.edu} ; Douglas R. Langbehn^a ; ^e ; Chiachi Wang^a ; James Mills^a ; Leigh J. Beglinger^a ; Megan M. Smith^a ; Eric A. Epping^a ; Jess G. Fiedorowicz^a ; ^f ; Kevin Duff^g ; Adam Ruggle^a ; David J. Moser^a ; ^b ; The PREDICT-HD Investigators of the Huntington Study Group
• 关键词：Psychiatric ; Antidepressant ; Neuroprotection ; Clinical trials ; SSRI
• 刊名：Psychiatry Research
• 出版年：2012
• 出版时间：30 April, 2012
• 年：2012
• 卷：196
• 期：2-3
• 页码：309-314
• 全文大小：415 K

文摘

Antidepressant usage in prodromal Huntington Disease (HD) remains uncharacterized, despite its relevance in designing experiments, studying outcomes of HD, and evaluating the efficacy of therapeutic interventions. We searched baseline medication logs of 787 prodromal HD and 215 healthy comparison (HC) participants for antidepressant use. Descriptive and mixed-effects logistic regression modeling characterized usage across participants. At baseline, approximately one in five prodromal HD participants took antidepressants. Of those, the vast majority took serotonergic antidepressants (selective serotonin reuptake inhibitor (SSRI) or serotonin/norepinephrine reuptake inhibitor (SNRI)). Significantly more prodromal HD participants used serotonergic antidepressants than their HC counterparts. Because of the prevalence of these medications, further analyses focused on this group alone. Mixed-effects logistic regression modeling revealed significant relationships of both closer proximity to diagnosis and female sex with greater likelihood to be prescribed a serotonergic antidepressant. More prodromal HD participants took antidepressants in general and specifically the subclass of serotonergic antidepressants than their at-risk counterparts, particularly when they were closer to predicted time of conversion to manifest HD. These propensities must be considered in studies of prodromal HD participants.